KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Castle Biosciences (CSTL) Amortization - Intangibles: 2021-2024

Historic Amortization - Intangibles for Castle Biosciences (CSTL) over the last 4 years, with Dec 2024 value amounting to $11.1 million.

  • Castle Biosciences' Amortization - Intangibles changed negligibly% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $36.9 million, marking a year-over-year increase of 307.40%. This contributed to the annual value of $11.1 million for FY2024, which is 23.22% up from last year.
  • As of FY2024, Castle Biosciences' Amortization - Intangibles stood at $11.1 million, which was up 23.22% from $9.0 million recorded in FY2023.
  • Castle Biosciences' 5-year Amortization - Intangibles high stood at $11.1 million for FY2024, and its period low was $2.0 million during FY2021.
  • In the last 3 years, Castle Biosciences' Amortization - Intangibles had a median value of $9.0 million in 2023 and averaged $9.5 million.
  • Data for Castle Biosciences' Amortization - Intangibles shows a peak YoY surged of 315.00% (in 2022) over the last 5 years.
  • Castle Biosciences' Amortization - Intangibles (Yearly) stood at $2.0 million in 2021, then skyrocketed by 315.00% to $8.3 million in 2022, then rose by 8.59% to $9.0 million in 2023, then rose by 23.22% to $11.1 million in 2024.